Annie Tanenhaus

Annie Tanenhaus has extensive work experience in the field of science and technology. Annie started their career as a Postdoctoral Researcher at the Carnegie Institution for Science in 2014. In 2015, they joined Encoded Therapeutics Inc. and has held various roles within the company since then. Annie began as a Scientist I/II and gradually progressed to become a Senior Scientist II. In 2021, they became the Director of Technology and most recently, in 2023, they were promoted to Senior Director. During their time at Encoded Therapeutics Inc., Annie has demonstrated their expertise and dedication in the scientific and technological aspects of their work.

Annie Tanenhaus pursued their education at Smith College from 2003 to 2007. During this time, they completed their Bachelor of Arts (BA) in Neuroscience. Later on, they attended the University of Wisconsin-Madison from 2008 to 2014 to obtain their Doctor of Philosophy (Ph.D.) in Neuroscience.